Literature DB >> 36129529

[New 2022 WHO classification of testicular tumours].

Alexander Fichtner1, Philipp Ströbel1, Felix Bremmer2.   

Abstract

The 5th edition of the WHO Classification of Tumours: Urinary and Male Genital Tumours includes some important revisions of the testicular tumour classifications, which are summarized in this article. They concern, for example, the definition of tumours of neuroectodermal and neuroendocrine origin. Furthermore, signet-ring stromal tumours and myoid gonadal stromal tumours are listed as separate entities in the section about sex-cord stromal tumours. Moreover, lymphatic neoplasia as well as soft tissue tumours of the urinary and male genital tract are each combined in a common section.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Embryonic-type neuroecotdermal tumour; Germ cell tumours; Myoid gonadal stromal tumour; Ovarian-type tumours; Sex cord stromal tumours

Mesh:

Year:  2022        PMID: 36129529     DOI: 10.1007/s00292-022-01112-1

Source DB:  PubMed          Journal:  Pathologie (Heidelb)        ISSN: 2731-7188


  36 in total

1.  Clinical and pathological features associated with the testicular tumor of the adrenogenital syndrome.

Authors:  Richard A Ashley; Shawn M McGee; Philip A Isotaolo; Stephen A Kramer; John C Cheville
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

2.  Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.

Authors:  Adam C Calaway; Isamu Tachibana; Timothy A Masterson; Richard S Foster; Lawrence H Einhorn; Clint Cary
Journal:  Urology       Date:  2019-02-23       Impact factor: 2.649

Review 3.  Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy.

Authors:  Daniel M Berney; Leendert H J Looijenga; Muhammad Idrees; J Wolter Oosterhuis; Ewa Rajpert-De Meyts; Thomas M Ulbright; Niels E Skakkebaek
Journal:  Histopathology       Date:  2016-04-12       Impact factor: 5.087

4.  Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.

Authors:  Gedske Daugaard; Maria Gry Gundgaard; Mette Saksø Mortensen; Mads Agerbæk; Niels Vilstrup Holm; Mikael Rørth; Hans von der Maase; Ib Jarle Christensen; Jakob Lauritsen
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

Review 5.  Testicular cancer--discoveries and updates.

Authors:  Nasser H Hanna; Lawrence H Einhorn
Journal:  N Engl J Med       Date:  2014-11-20       Impact factor: 91.245

Review 6.  Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors.

Authors:  Mahul B Amin
Journal:  Mod Pathol       Date:  2005-02       Impact factor: 7.842

7.  Primary signet-ring stromal tumour of the testis: case report with literature review.

Authors:  Alexander Fichtner; Annette Fisseler-Eckhoff; Wolfgang Kramer; Heinz Joachim Radzun; Philipp Ströbel; Felix Bremmer
Journal:  APMIS       Date:  2019-01       Impact factor: 3.205

8.  Appendageal tumors and tumor-like lesions of the testis and paratestis: a 32-year experience at a single institution.

Authors:  Khaleel I Al-Obaidy; Fatimah I Alruwaii; Thomas M Ulbright; Muhammad T Idrees
Journal:  Hum Pathol       Date:  2020-06-30       Impact factor: 3.466

9.  The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification.

Authors:  Maurizio Colecchia; Alessia Bertolotti; Biagio Paolini; Francesca Giunchi; Andrea Necchi; Anna M Paganoni; Costantino Ricci; Michelangelo Fiorentino; Gian P Dagrada
Journal:  Histopathology       Date:  2020-09-24       Impact factor: 5.087

10.  Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.

Authors:  Tarec Christoffer El-Galaly; Diego Villa; Musa Alzahrani; Jakob Werner Hansen; Laurie H Sehn; Don Wilson; Peter de Nully Brown; Annika Loft; Victor Iyer; Hans Erik Johnsen; Kerry J Savage; Joseph M Connors; Martin Hutchings
Journal:  Am J Hematol       Date:  2015-11       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.